Damalie Nakanjako

Last updated

Damalie Nakanjako
Born1974 (age 49–50)
Uganda
NationalityUgandan
Education Makerere University
(Bachelor of Medicine and Bachelor of Surgery)
(Master of Medicine in Internal Medicine)
University of Antwerp
(Doctor of Philosophy
Occupations
Years active2000–present
Known forAcademics and Research
Title Principal and Professor of Medicine at Makerere University College of Health Sciences

Damalie Nakanjako, (born 1974) is a Ugandan specialist physician, internist, immunologist, infectious diseases consultant, academic and researcher, who serves as the Principal and Professor of Medicine at Makerere University College of Health Sciences. [1] Immediately prior to her present position, she served as Dean of Makerere University School of Medicine, from 2019 until 17 February 2021. [2]

Contents

Background and education

She was born in the Buganda Region of Uganda in the 1970s. After attending Maryhill High School and later Gayaza High School, she was admitted to Makerere University, where she studied human medicine. She graduated with a Bachelor of Medicine and Bachelor of Surgery (MBChB) degree in 1999. She followed that with a Master of Medicine (MMed) degree in Internal Medicine, also from Makerere University. Her third degree was a Doctor of Philosophy (PhD) in Biomedical Science, obtained from the University of Antwerp, in Belgium, in 2010. According to her online curriculum vitae, she spent the years between 2011 and 2013 at the Infectious Diseases Institute, working as a postdoctoral fellow and at Uganda Virus Research Institute, working as a research scholar. [3]

Career

Nakanjako interned at Mulago Hospital in Internal Medicine and Obstetrics and Genecology, from 1998 until 1999. She spent another year at the same hospital as a medical officer. She then spent two years as a specialist medical officer at the CDC field station in Tororo, Uganda. In 2002, she returned to Mulago to pursue her master's degree. [3]

After her MMed studies she focused on clinical research in HIV/AIDS and she started lecturing in internal medicine at Makerere in 2007. Following her PhD studies, the Welcome Trust awarded her a scholarship to undertake a postdoctoral fellowship at Makerere, based at the Infectious Diseases Institute of the university. [3]

Makerere University appointed Nakanjako as Associate Professor of Medicine in 2013, serving in that capacity for five years. In 2018, she made full Professor. [3] She is the scientific Director of the Translational laboratory at the Infectious Diseases Institute, Makerere University College of Health Sciences. Professor Nakanjako is the Director of the ADAPT Africa One Health Network with Seven countries in sub-Saharan Africa and Germany https://adaptonehealth.net/our-team/#uganda and she leads the Africa-Europe Cluster of Excellence in Infection Immunity and Inflammation Research https://www.the-guild.eu/africa-europe-core/Translational%20Research-in-Infection-Immunity-an-Inflammation.html. Professor Damalie Nakanjako is a receipient of the 2022 TWAS-Abdool Karim Award in Biological Sciences, in recognition of her achievements in biological sciences. The award recognizes women scientists from low-income African countries

Other considerations

Professor Nakanjako has authored or co-written over 100 peer-reviewed articles, in the areas of her medical expertise in different medical journals. [4] Some of them include; Effects of HIV infection and ART on phenotype and function of circulating monocytes, natural killer, and innate lymphoid cells. [5] Access to HIV/AIDS care for mothers and children in sub-Saharan Africa: adherence to the postnatal PMTCT program. [6] Diversity of vaginal microbiota in sub-Saharan Africa and its effects on HIV transmission and prevention. [7] Subclinical Atherosclerosis among HIV-Infected Adults Attending HIV/AIDS Care at Two Large Ambulatory HIV Clinics in Uganda. [8] Low HIV viral suppression rates following the intensive adherence counseling (IAC) program for children and adolescents with viral failure in public health facilities in Uganda. [9] Acceptance of routine testing for HIV among adult patients at the medical emergency unit at a National Referral Hospital in Kampala, Uganda. [10] High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort. [11] Use of RDTs to improve malaria diagnosis and fever case management at primary health care facilities in Uganda. [12] Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. [13] Mentorship needs at academic institutions in resource-limited settings: a survey at makerere university college of health sciences. [14] Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial. [15] Challenges faced by caregivers of virally non-suppressed children on the intensive adherence counselling program in Uganda: a qualitative study. [16] Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda. [17] Acceptability and predictors of uptake of Anti-retroviral Pre-exposure Prophylaxis (PrEP) among fishing communities in Uganda: A cross-sectional discrete choice experiment survey. [18] Frequency and impact of suboptimal immune recovery on first-line antiretroviral therapy within the International Epidemiologic Databases to evaluate AIDS in East Africa. [19] and Strategies for retention of heterosexual men in HIV care in sub-Saharan Africa: A systematic review. [20]

See also

Related Research Articles

The management of HIV/AIDS normally includes the use of multiple antiretroviral drugs as a strategy to control HIV infection. There are several classes of antiretroviral agents that act on different stages of the HIV life-cycle. The use of multiple drugs that act on different viral targets is known as highly active antiretroviral therapy (HAART). HAART decreases the patient's total burden of HIV, maintains function of the immune system, and prevents opportunistic infections that often lead to death. HAART also prevents the transmission of HIV between serodiscordant same-sex and opposite-sex partners so long as the HIV-positive partner maintains an undetectable viral load.

Following infection with HIV-1, the rate of clinical disease progression varies between individuals. Factors such as host susceptibility, genetics and immune function, health care and co-infections as well as viral genetic variability may affect the rate of progression to the point of needing to take medication in order not to develop AIDS.

Syndemics is the evaluation of how social and health conditions arise, in what ways they interact, and what upstream drivers may produce their interactions. The word is a blend of "synergy" and "epidemics". The idea of syndemics is that no disease exists in isolation and that often population health can be understood through a confluence of factors that produces multiple health conditions that afflict some populations and not others. Syndemics are not like pandemics ; instead, syndemics reflect population-level trends within certain states, regions, cities, or towns.

Frederick Wabwire-Mangen is a Ugandan physician, public health specialist and medical researcher. Currently he is Professor of Epidemiology and Head of Department of Epidemiology & Biostatistics at Makerere University School of Public Health. Wabwire-Mangen also serves as the Chairman of Council of Kampala International University and a founding member of Accordia Global Health Foundation’s Academic Alliance

<span class="mw-page-title-main">David Serwadda</span> Ugandan physician

David M. Serwadda is a Ugandan physician, medical researcher, academic, public health specialist and medical administrator. Currently he is a Professor of Public Health at Makerere University School of Public Health, one of the schools of Makerere University College of Health Sciences, a semi-autonomous constituent college of Makerere University, the oldest university in Uganda. Serwadda is also a founding member of Accordia Global Health Foundation's Academic Alliance.

The Infectious Diseases Institute (IDI), established within Makerere University, is a Ugandan not-for-profit organization which aims to strengthen health systems in Africa, with a strong emphasis on infectious diseases; through research and capacity development. In pursuit of its mission both in Uganda and Sub-Saharan Africa, IDI provides care to People Living with HIV (PLHIV) and other infectious diseases, builds capacity among healthcare workers through training and ongoing support, maintains a focus on prevention, and carries out relevant research.

Celestino Obua is a Ugandan physician, pharmacologist, academic and academic administrator. He is the current Vice Chancellor of Mbarara University of Science and Technology. He assumed that position on Friday, 24 October 2014. Prior to that, he served as the Deputy Principal of Makerere University College of Health Sciences.

Harriet Mayanja-Kizza is a Ugandan physician, researcher, and academic administrator. She is the former Dean of Makerere University School of Medicine, the oldest medical school in East Africa, established in 1924.

<span class="mw-page-title-main">Elioda Tumwesigye</span> Ugandan politician

Elioda Tumwesigye is a Ugandan politician, physician, and epidemiologist who has served as minister of science, technology and innovation in the cabinet of Uganda since June 2016. From March 2015 until June 2016, he served as the minister of health.

Treatment as prevention (TasP) is a concept in public health that promotes treatment as a way to prevent and reduce the likelihood of HIV illness, death and transmission from an infected individual to others. Expanding access to earlier HIV diagnosis and treatment as a means to address the global epidemic by preventing illness, death and transmission was first proposed in 2000 by Garnett et al. The term is often used to talk about treating people that are currently living with human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) to prevent illness, death and transmission. Although some experts narrow this to only include preventing infections, treatment prevents illnesses such as tuberculosis and has been shown to prevent death. In relation to HIV, antiretroviral therapy (ART) is a three or more drug combination therapy that is used to decrease the viral load, or the measured amount of virus, in an infected individual. Such medications are used as a preventative for infected individuals to not only spread the HIV virus to their negative partners but also improve their current health to increase their lifespans. When taken correctly, ART is able to diminish the presence of the HIV virus in the bodily fluids of an infected person to a level of undetectability. Consistent adherence to an ARV regimen, monitoring, and testing are essential for continued confirmed viral suppression. Treatment as prevention rose to great prominence in 2011, as part of the HPTN 052 study, which shed light on the benefits of early treatment for HIV positive individuals.

Moses R Kamya, is a Ugandan physician, academic, researcher and academic administrator, who serves as Professor and Chair of the Department Medicine, Makerere University School of Medicine, a component of Makerere University College of Health Sciences.

Cissy Kityo Mutuluuza, is a Ugandan physician, epidemiologist and medical researcher. She is the Executive Director of the Joint Clinical Research Centre, a government-owned medical research institution in Uganda, specializing in HIV/AIDS treatment and management.

Rhoda Wanyenze is a physician, public health consultant, academic and medical administrator, who serves as the Dean of Makerere University School of Public Health, a component school of Makerere University College of Health Sciences, which is part of Makerere University, Uganda's oldest and largest public university.

William Bazeyo is a Ugandan physician, public health specialist, academic, researcher, and academic administrator. From September 2017 until October 2020, he was the deputy vice chancellor in charge of finance and administration at Makerere University. During the preceding eight years, he was the dean of the Makerere University School of Public Health.

Sarah Ssali is a Ugandan social scientist, researcher, academic and academic administrator, who is an associate professor and dean of the School of Gender Studies at Makerere University, Uganda's oldest and largest public university.

Roy D. Mugerwa was a Ugandan physician, cardiologist and researcher. His contribution to the world of academics include being a Professor Emeritus at Makerere University College of Health Sciences in Kampala, cardiology in Uganda, researching HIV/AIDS and tuberculosis, and his efforts to find an effective HIV vaccine.

Professor Paul Waako, is a Ugandan pharmacologist, academic and academic administrator, who serves as the Vice Chancellor of Busitema University, a public university in the Eastern Region of Uganda, since 1 May 2019.

Fred Nalugoda is a public health researcher studying HIV/AIDS in rural Uganda for over 20 years, mainly through surveillance and field work. He currently serves as the Program Director of a research station in Kalisizo in Uganda as part of his continued work at the Rakai Health Sciences Program (RHSP).

Andrew Ddungu Kambugu is a Ugandan physician who serves as The Sande-McKinnell Executive Director at Uganda Infectious Disease Institute and a Honorary Senior lecturer at Makerere University College of Sciences. He is also an Adjunct Associate Professor at the University of Minnesota. In July 2020, he was appointed to the United Nations 2021 Food System Scientific Group.

<span class="mw-page-title-main">Etheldreda Nakimuli-Mpungu</span> Ugandan Mental health programme developer

Etheldreda Nakimuli-Mpungu is a professor, researcher, epidemiologist and psychiatrist at the Department of Psychiatry in the Faculty of Medicine, Makerere University in Uganda. Her research is particularly focused on supportive group psychotherapy as a first-line treatment for depression in people with HIV. She is one of only five recipients of the Elsevier Foundation Award for Early Career Women Scientists in the Developing World in Biological Sciences, as well as listed at one of the BBC's 100 Women in 2020.

References

  1. ↑ MUCHS (21 April 2021). "Collège Profile of Makerere University Collège of Health Sciences (MUCHS)". Kampala. Retrieved 21 April 2021.
  2. ↑ Brenda Namatta (8 February 2021). "Dr. Nakimuli Takes Over Leadership of School of Medicine". Kampala: Makerere University School of Medicine. Archived from the original on 23 July 2021. Retrieved 21 April 2021.
  3. 1 2 3 4 Damalie Nakanjako (2019). "Curriculum Vitae of Professor Damalie Nakanjako, Makerere College of Health Sciences". University of California. Archived from the original (Cached from the original on 21 April 2021) on 23 April 2021. Retrieved 21 April 2021.
  4. ↑ Researchgate (21 April 2021). "Partial Listing of Publications By Professor Damalie Nakanjako" . Retrieved 21 April 2021.
  5. ↑ Nabatanzi, Rose; Cose, Stephen; Joloba, Moses; Jones, Sarah Rowland; Nakanjako, Damalie (15 March 2018). "Effects of HIV infection and ART on phenotype and function of circulating monocytes, natural killer, and innate lymphoid cells". AIDS Research and Therapy. 15 (1): 7. doi: 10.1186/s12981-018-0194-y . ISSN   1742-6405. PMC   5853105 . PMID   29544508.
  6. ↑ Nassali, Mercy; Nakanjako, Damalie; Kyabayinze, Daniel; Beyeza, Jolly; Okoth, Anthony; Mutyaba, Twaha (1 September 2009). "Access to HIV/AIDS care for mothers and children in sub-Saharan Africa: adherence to the postnatal PMTCT program". AIDS Care. 21 (9): 1124–1131. doi:10.1080/09540120802707467. ISSN   0954-0121. PMID   20024771.
  7. ↑ Bayigga, Lois; Kateete, David P.; Anderson, Deborah J.; Sekikubo, Musa; Nakanjako, Damalie (1 February 2019). "Diversity of vaginal microbiota in sub-Saharan Africa and its effects on HIV transmission and prevention". American Journal of Obstetrics and Gynecology. 220 (2): 155–166. doi: 10.1016/j.ajog.2018.10.014 . ISSN   0002-9378. PMC   10715630 .
  8. ↑ Ssinabulya, Isaac; Kayima, James; Longenecker, Chris; Luwedde, Mary; Semitala, Fred; Kambugu, Andrew; Ameda, Faith; Bugeza, Sam; McComsey, Grace; Freers, Juergen; Nakanjako, Damalie (28 February 2014). "Subclinical Atherosclerosis among HIV-Infected Adults Attending HIV/AIDS Care at Two Large Ambulatory HIV Clinics in Uganda". PLOS ONE. 9 (2): e89537. doi: 10.1371/journal.pone.0089537 . ISSN   1932-6203. PMC   3938501 . PMID   24586854.
  9. ↑ Nasuuna, Esther; Kigozi, Joanita; Babirye, Lillian; Muganzi, Alex; Sewankambo, Nelson K.; Nakanjako, Damalie (22 August 2018). "Low HIV viral suppression rates following the intensive adherence counseling (IAC) program for children and adolescents with viral failure in public health facilities in Uganda". BMC Public Health. 18 (1): 1048. doi: 10.1186/s12889-018-5964-x . ISSN   1471-2458. PMC   6103875 . PMID   30134880.
  10. ↑ Nakanjako, Damalie; Kamya, Moses; Daniel, Kyabayinze; Mayanja-Kizza, Harriet; Freers, Jurgen; Whalen, Christopher; Katabira, Elly (1 September 2007). "Acceptance of Routine Testing for HIV among Adult Patients at the Medical Emergency Unit at a National Referral Hospital in Kampala, Uganda". AIDS and Behavior. 11 (5): 753–758. doi:10.1007/s10461-006-9180-9. ISSN   1573-3254.
  11. ↑ Nakanjako, Damalie; Ssewanyana, Isaac; Mayanja-Kizza, Harriet; Kiragga, Agnes; Colebunders, Robert; Manabe, Yukari C.; Nabatanzi, Rose; Kamya, Moses R.; Cao, Huyen (8 February 2011). "High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort". BMC Infectious Diseases. 11 (1): 43. doi: 10.1186/1471-2334-11-43 . ISSN   1471-2334. PMC   3065409 . PMID   21299909.
  12. ↑ Kyabayinze, Daniel J.; Asiimwe, Caroline; Nakanjako, Damalie; Nabakooza, Jane; Counihan, Helen; Tibenderana, James K. (12 July 2010). "Use of RDTs to improve malaria diagnosis and fever case management at primary health care facilities in Uganda". Malaria Journal. 9 (1): 200. doi: 10.1186/1475-2875-9-200 . ISSN   1475-2875. PMC   2914063 . PMID   20624312.
  13. ↑ Mermin, Jonathan; Lule, John; Ekwaru, John Paul; Malamba, Samuel; Downing, Robert; Ransom, Ray; Kaharuza, Frank; Culver, David; Kizito, Francis; Bunnell, Rebecca; Kigozi, Aminah; Nakanjako, Damalie; Wafula, Winnie; Quick, Robert (16 October 2004). "Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda". The Lancet. 364 (9443): 1428–1434. doi:10.1016/S0140-6736(04)17225-5. ISSN   0140-6736.
  14. ↑ Nakanjako, Damalie; Byakika-Kibwika, Pauline; Kintu, Kenneth; Aizire, Jim; Nakwagala, Fred; Luzige, Simon; Namisi, Charles; Mayanja-Kizza, Harriet; Kamya, Moses R. (29 July 2011). "Mentorship needs at academic institutions in resource-limited settings: a survey at makerere university college of health sciences". BMC Medical Education. 11 (1): 53. doi: 10.1186/1472-6920-11-53 . ISSN   1472-6920. PMC   3170866 . PMID   21801406.
  15. ↑ Nakanjako, Damalie; Ssinabulya, Isaac; Nabatanzi, Rose; Bayigga, Lois; Kiragga, Agnes; Joloba, Moses; Kaleebu, Pontiano; Kambugu, Andrew D.; Kamya, Moses R.; Sekaly, Rafick; Elliott, Alison; Mayanja-Kizza, Harriet (2015). "Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial". Tropical Medicine & International Health. 20 (3): 380–390. doi:10.1111/tmi.12442. PMC   4529480 . PMID   25441397.
  16. ↑ Nasuuna, Esther; Kigozi, Joanita; Muwanguzi, Patience A.; Babirye, Joyce; Kiwala, Laura; Muganzi, Alex; Sewankambo, Nelson; Nakanjako, Damalie (7 March 2019). "Challenges faced by caregivers of virally non-suppressed children on the intensive adherence counselling program in Uganda: a qualitative study". BMC Health Services Research. 19 (1): 150. doi: 10.1186/s12913-019-3963-y . ISSN   1472-6963. PMC   6407183 . PMID   30845951.
  17. ↑ Nakiyingi, Lydia; Ssengooba, Willy; Nakanjako, Damalie; Armstrong, Derek; Holshouser, Molly; Kirenga, Bruce J.; Shah, Maunank; Mayanja-Kizza, Harriet; Joloba, Moses L.; Ellner, Jerrold J.; Dorman, Susan E.; Manabe, Yukari C. (15 February 2015). "Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda". BMC Infectious Diseases. 15 (1): 62. doi: 10.1186/s12879-015-0812-4 . ISSN   1471-2334. PMC   4332438 . PMID   25888317.
  18. ↑ Kuteesa, Monica O.; Quaife, Mathew; Biraro, Sam; Katumba, Kenneth R.; Seeley, Janet; Kamali, Anatoli; Nakanjako, Damalie (1 October 2019). "Acceptability and Predictors of Uptake of Anti-retroviral Pre-exposure Prophylaxis (PrEP) Among Fishing Communities in Uganda: A Cross-Sectional Discrete Choice Experiment Survey". AIDS and Behavior. 23 (10): 2674–2686. doi:10.1007/s10461-019-02418-7. ISSN   1573-3254.
  19. ↑ Nakanjako, Damalie; Kiragga, Agnes N.; Musick, Beverly S.; Yiannoutsos, Constantin T.; Wools-Kaloustian, Kara; Diero, Lameck; Oyaro, Patrick; Lugina, Emanuel; Ssali, John C.; Kambugu, Andrew; Easterbrook, Philippa (31 July 2016). "Frequency and impact of suboptimal immune recovery on first-line antiretroviral therapy within the International Epidemiologic Databases to Evaluate AIDS in East Africa". AIDS. 30 (12): 1913–1922. doi:10.1097/QAD.0000000000001085. ISSN   0269-9370. PMC   5438045 . PMID   26959510.
  20. ↑ Kusemererwa, Sylvia; Akena, Dickens; Nakanjako, Damalie; Kigozi, Joanita; Nanyunja, Regina; Nanfuka, Mastula; Kizito, Bennet; Okello, Joseph Mugisha; Sewankambo, Nelson Kawulukusi (4 February 2021). "Strategies for retention of heterosexual men in HIV care in sub-Saharan Africa: A systematic review". PLOS ONE. 16 (2): e0246471. doi: 10.1371/journal.pone.0246471 . ISSN   1932-6203. PMC   7861356 . PMID   33539424.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.